Pressor responses to the α1-adrenoceptor agonist cirazoline: effects of captopril, phenoxybenzamine and nifedipine

Reza Tabrizchi, Christopher Triggle

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We have examined the effects of captopril on pressor responses to the selective α1-adrenoceptor agonist cirazoline in the pithed rat preparation following treatment with phenoxybenzamine and/or nifedipine. Pretreatment with captopril reduced the pressor responses to cirazoline and displaced the dose-response curve for this agonist to the right, significantly increasing the ED50 without altering the maximum response. Pretreatment with phenoxybenzamine accentuated the inhibitory actions of captopril and a combination of phenoxybenzamine and captopril significantly increased the ED50 without altering the maximum response. Administration of nifedipine in animals, which had already received phenoxybenzamine and captopril, led to a further displacement to the right of the cirazoline dose-response curve. The ED50 was found to be significantly increased and the maximum response was now significantly depressed. Captopril produced further additive inhibition with nifedipine and phenoxybenzamine of the vasoconstrictor effects of cirazoline. These data indicate, perhaps not surprisingly, that the cellular basis for the inhibitory effects of captopril is different from that of nifedine and phenoxybenzamine, however, more importantly, that captopril may directly, or indirectly, inhibit receptor-operated cation channel mediated pressor responses.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalEuropean Journal of Pharmacology
Volume251
Issue number1
DOIs
Publication statusPublished - 4 Jan 1994
Externally publishedYes

Fingerprint

Phenoxybenzamine
Captopril
Nifedipine
Adrenergic Receptors
cirazoline
Vasoconstrictor Agents
Cations

Keywords

  • Angiotensin-converting enzyme inhibitor
  • Ca channel antagonist
  • Phenoxybenzamine
  • Receptor reserve
  • α-Adrenoceptor, vascular

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Pressor responses to the α1-adrenoceptor agonist cirazoline : effects of captopril, phenoxybenzamine and nifedipine. / Tabrizchi, Reza; Triggle, Christopher.

In: European Journal of Pharmacology, Vol. 251, No. 1, 04.01.1994, p. 15-20.

Research output: Contribution to journalArticle

@article{c2d8cd11b6224d6687dd0c5833e15726,
title = "Pressor responses to the α1-adrenoceptor agonist cirazoline: effects of captopril, phenoxybenzamine and nifedipine",
abstract = "We have examined the effects of captopril on pressor responses to the selective α1-adrenoceptor agonist cirazoline in the pithed rat preparation following treatment with phenoxybenzamine and/or nifedipine. Pretreatment with captopril reduced the pressor responses to cirazoline and displaced the dose-response curve for this agonist to the right, significantly increasing the ED50 without altering the maximum response. Pretreatment with phenoxybenzamine accentuated the inhibitory actions of captopril and a combination of phenoxybenzamine and captopril significantly increased the ED50 without altering the maximum response. Administration of nifedipine in animals, which had already received phenoxybenzamine and captopril, led to a further displacement to the right of the cirazoline dose-response curve. The ED50 was found to be significantly increased and the maximum response was now significantly depressed. Captopril produced further additive inhibition with nifedipine and phenoxybenzamine of the vasoconstrictor effects of cirazoline. These data indicate, perhaps not surprisingly, that the cellular basis for the inhibitory effects of captopril is different from that of nifedine and phenoxybenzamine, however, more importantly, that captopril may directly, or indirectly, inhibit receptor-operated cation channel mediated pressor responses.",
keywords = "Angiotensin-converting enzyme inhibitor, Ca channel antagonist, Phenoxybenzamine, Receptor reserve, α-Adrenoceptor, vascular",
author = "Reza Tabrizchi and Christopher Triggle",
year = "1994",
month = "1",
day = "4",
doi = "10.1016/0014-2999(94)90437-5",
language = "English",
volume = "251",
pages = "15--20",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Pressor responses to the α1-adrenoceptor agonist cirazoline

T2 - effects of captopril, phenoxybenzamine and nifedipine

AU - Tabrizchi, Reza

AU - Triggle, Christopher

PY - 1994/1/4

Y1 - 1994/1/4

N2 - We have examined the effects of captopril on pressor responses to the selective α1-adrenoceptor agonist cirazoline in the pithed rat preparation following treatment with phenoxybenzamine and/or nifedipine. Pretreatment with captopril reduced the pressor responses to cirazoline and displaced the dose-response curve for this agonist to the right, significantly increasing the ED50 without altering the maximum response. Pretreatment with phenoxybenzamine accentuated the inhibitory actions of captopril and a combination of phenoxybenzamine and captopril significantly increased the ED50 without altering the maximum response. Administration of nifedipine in animals, which had already received phenoxybenzamine and captopril, led to a further displacement to the right of the cirazoline dose-response curve. The ED50 was found to be significantly increased and the maximum response was now significantly depressed. Captopril produced further additive inhibition with nifedipine and phenoxybenzamine of the vasoconstrictor effects of cirazoline. These data indicate, perhaps not surprisingly, that the cellular basis for the inhibitory effects of captopril is different from that of nifedine and phenoxybenzamine, however, more importantly, that captopril may directly, or indirectly, inhibit receptor-operated cation channel mediated pressor responses.

AB - We have examined the effects of captopril on pressor responses to the selective α1-adrenoceptor agonist cirazoline in the pithed rat preparation following treatment with phenoxybenzamine and/or nifedipine. Pretreatment with captopril reduced the pressor responses to cirazoline and displaced the dose-response curve for this agonist to the right, significantly increasing the ED50 without altering the maximum response. Pretreatment with phenoxybenzamine accentuated the inhibitory actions of captopril and a combination of phenoxybenzamine and captopril significantly increased the ED50 without altering the maximum response. Administration of nifedipine in animals, which had already received phenoxybenzamine and captopril, led to a further displacement to the right of the cirazoline dose-response curve. The ED50 was found to be significantly increased and the maximum response was now significantly depressed. Captopril produced further additive inhibition with nifedipine and phenoxybenzamine of the vasoconstrictor effects of cirazoline. These data indicate, perhaps not surprisingly, that the cellular basis for the inhibitory effects of captopril is different from that of nifedine and phenoxybenzamine, however, more importantly, that captopril may directly, or indirectly, inhibit receptor-operated cation channel mediated pressor responses.

KW - Angiotensin-converting enzyme inhibitor

KW - Ca channel antagonist

KW - Phenoxybenzamine

KW - Receptor reserve

KW - α-Adrenoceptor, vascular

UR - http://www.scopus.com/inward/record.url?scp=0028125982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028125982&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(94)90437-5

DO - 10.1016/0014-2999(94)90437-5

M3 - Article

C2 - 7907984

AN - SCOPUS:0028125982

VL - 251

SP - 15

EP - 20

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -